Athira Pharma Inc
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
LONA$4.47+1.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(in thousands, except share and per share amounts)
| September 30, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| (unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $68,856 | $90,584 |
| Restricted cash, current | 8,373 | — |
| Short-term investments | — | 56,835 |
| Prepaid expenses and other current assets | 3,145 | 5,682 |
| Insurance recovery receivable related to legal settlement (Note 7) | 1,628 | 1,628 |
| Total current assets | 82,002 | 154,729 |
| Restricted cash, non-current | 631 | 631 |
| Property and equipment, net | 2,687 | 3,388 |
| Operating lease right-of-use asset | 871 | 1,049 |
| Other long-term assets | 55 | 448 |
| Total assets | $86,246 | $160,245 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $388 | $129 |
| Accrued liabilities | 16,961 | 18,343 |
| Accrued legal settlement (Note 7) | 10,000 | 10,000 |
| Current operating lease liability | 402 | 368 |
| Total current liabilities | 27,751 | 28,840 |
| Operating lease liability, less current portion | 912 | 1,217 |
| Total liabilities | 28,663 | 30,057 |
| Stockholders' equity: | ||
| Common stock, $0.0001 par value; 900,000,000 shares authorized at September 30, 2024 and December 31, 2023, respectively; 38,669,073 and 38,172,603 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively | 4 | 4 |
| Additional paid-in capital | 448,719 | 439,739 |
| Accumulated other comprehensive income (loss) | 3 | (349) |
| Accumulated deficit | (391,143) | (309,206) |
| Total stockholders' equity | 57,583 | 130,188 |
| Total liabilities and stockholders' equity | $86,246 | $160,245 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.